RAPP Rapport Therapeutics, Inc.

Fundamentals / CIK 0002012593 / USD

Rapport Therapeutics, Inc. reported $418.6M in total assets and a net loss of $150.5M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RAPP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$104.2MFY 2023 Net Income: -$34.79M2023FY 2024 Net Income: -$78.31M2024FY 2025 Net Income: -$111.5M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $94.79M $60.94M $28.00M
Total Operating Expenses $125.1M $83.06M $36.18M
Operating Income -$125.1M -$83.06M -$36.18M
EBITDA -$124.1M -$82.22M -$36.07M
Interest Income $13.62M $12.14M $2.53M
Income Before Tax -- -$78.31M -$34.78M
Income Tax Expense $0 $0 $10K
Net Income -$111.5M -$78.31M -$34.79M
Basic EPS -$2.86 -$3.78 -$23.10
Diluted EPS -$2.86 -$3.78 -$23.10
Basic Shares Outstanding 38.9M 20.7M 1.5M
Diluted Shares Outstanding 38.9M 20.7M 1.5M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $20.00M -- $0 $0 $0 --
Research & Development $34.32M $51.41M $32.72M $30.26M $22.28M $22.68M $19.57M $17.20M
Selling, General & Admin $9.77M $9.39M $11.50M -- $7.71M $6.82M $7.54M --
Total Operating Expenses $44.09M $60.81M $44.22M $38.51M $29.99M $29.50M $27.11M $23.52M
Operating Income -$44.09M -$60.81M -$24.21M -$38.51M -$29.99M -$29.50M -$27.11M -$23.52M
EBITDA -$43.89M -$60.59M -$23.99M -$38.24M -$29.73M -$29.24M -$26.86M -$23.26M
Interest Income $3.85M $4.19M $4.36M $4.75M $3.06M $2.76M $3.04M $3.54M
Net Income -$40.23M -$56.62M -$19.86M -$33.76M -$26.93M -$26.73M -$24.06M -$19.98M
Basic EPS -$0.84 -$1.19 -$0.42 -- -$0.71 -$0.75 -$0.68 --
Diluted EPS -$0.84 -$1.19 -$0.42 -- -$0.71 -$0.75 -$0.68 --
Basic Shares Outstanding 47.8M 47.5M 47.2M -- 37.9M 35.4M 35.3M --
Diluted Shares Outstanding 47.8M 47.5M 47.2M -- 37.9M 35.4M 35.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $52.65M $56.80M $70.17M
Short-Term Investments $437.9M $248.5M $77.31M
Cash & Short-Term Investments $490.5M $305.3M $147.5M
Accounts Receivable, Net $0 -- --
Total Current Assets $498.6M $309.8M $150.9M
Property, Plant & Equipment, Net $2.98M $3.53M $1.92M
Other Non-Current Assets $985K $160K $551K
Total Non-Current Assets $13.87M $5.13M $4.55M
Total Assets $512.4M $314.9M $155.4M
Accounts Payable $4.19M $1.95M $2.50M
Total Current Liabilities $19.05M $8.77M $8.80M
Total Non-Current Liabilities $8.73M $739K $5.68M
Total Liabilities $27.78M $9.51M $14.48M
Total Debt (incl. Leases) $11.48M $1.48M $2.15M
Common Stock $48K $37K $4.0K
Retained Earnings -$235.2M -$123.7M -$45.44M
Accumulated Other Comp. Income $546K -$522K $4.0K
Total Stockholders' Equity $484.7M $305.4M -$25.63M
Total Equity $484.7M $305.4M -$25.63M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $74.75M $63.61M $78.06M $52.65M $251.4M $55.07M $57.60M $56.80M
Short-Term Investments $320.3M $372.5M $398.7M $437.9M $261.7M $205.4M $227.8M $248.5M
Cash & Short-Term Investments $395.0M $436.1M $476.8M $490.5M $513.0M $260.4M $285.4M $305.3M
Accounts Receivable, Net $171K $293K $58K $0 -- -- -- --
Total Current Assets $407.4M $446.9M $484.7M $498.6M $520.7M $270.2M $291.0M $309.8M
Property, Plant & Equipment, Net $1.96M $2.34M $2.52M $2.98M $3.12M $3.17M $3.40M $3.53M
Other Non-Current Assets $1.09M $1.06M $1.06M $985K $1.07M $1.03M $211K $160K
Total Non-Current Assets $11.18M $12.13M $12.90M $13.87M $14.66M $15.25M $11.09M $5.13M
Total Assets $418.6M $459.0M $497.6M $512.4M $535.3M $285.5M $302.1M $314.9M
Accounts Payable $1.72M $2.80M $6.56M $4.19M $3.23M $3.18M $2.14M $1.95M
Total Current Liabilities $20.30M $28.42M $17.90M $19.05M $14.32M $11.88M $9.38M $8.77M
Total Non-Current Liabilities $7.07M $7.63M $8.19M $8.73M $9.39M $10.10M $6.83M $739K
Total Liabilities $27.37M $36.06M $26.09M $27.78M $23.71M $21.98M $16.22M $9.51M
Total Debt (incl. Leases) $9.39M $10.11M $10.80M $11.48M $11.87M $11.86M $7.84M $1.48M
Common Stock $48K $48K $48K $48K $48K $37K $37K $37K
Retained Earnings -$351.9M -$311.7M -$255.1M -$235.2M -$201.5M -$174.5M -$147.8M -$123.7M
Accumulated Other Comp. Income -$2.12M -$1.27M -$505K $546K $145K -$76K -$95K -$522K
Total Stockholders' Equity $391.2M $422.9M $471.5M $484.7M $511.6M $263.5M $285.8M $305.4M
Total Equity $391.2M $422.9M $471.5M $484.7M $511.6M $263.5M $285.8M $305.4M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$111.5M -$78.31M -$34.79M
Depreciation & Amortization $1.02M $839K $112K
Stock-Based Compensation $18.86M $10.23M $3.52M
Change in Payables $2.21M -$346K $856K
Operating Cash Flow -$87.47M -$64.83M -$27.18M
Capital Expenditure -$616K -$2.40M -$1.64M
Free Cash Flow -$88.09M -$67.23M -$28.82M
Purchases of Investments -$354.8M -$377.5M -$77.22M
Sales & Maturities of Investments $167.9M $209.8M --
Investing Cash Flow -$187.5M -$170.1M -$78.86M
Common Stock Issued -- -- $54K
Financing Cash Flow $270.8M $221.6M $145.1M
Net Change in Cash -$4.16M -$13.34M $39.09M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$40.23M -$56.62M -$19.86M -$33.76M -$26.93M -$26.73M -$24.06M -$19.98M
Depreciation & Amortization $198K $212K $227K $265K $256K $252K $244K $260K
Stock-Based Compensation $7.63M $7.20M $6.96M $5.69M $4.74M $4.39M $4.04M $3.21M
Change in Receivables $122K -$235K -$58K -- $0 $0 $0 --
Change in Payables -$1.09M -$3.68M $2.31M $1.18M -$179K $1.03M $185K $648K
Operating Cash Flow -$41.63M -$41.45M -$13.06M -$24.70M -$17.46M -$25.07M -$20.24M -$14.45M
Capital Expenditure $0 -$78K -$86K -$169K -$134K -$22K -$291K -$226K
Free Cash Flow -$41.63M -$41.53M -$13.15M -$24.87M -$17.60M -$25.09M -$20.53M -$14.67M
Purchases of Investments -$14.39M -$39.67M -$30.37M -$197.1M -$101.6M -$12.86M -$43.23M -$84.56M
Sales & Maturities of Investments $65.25M $65.16M $58.32M $22.92M $44.98M $35.48M $64.56M $116.7M
Investing Cash Flow $51.06M $25.60M $37.94M -$174.3M -$56.78M $22.60M $21.03M $31.93M
Financing Cash Flow $1.71M $1.41M $531K $311K $270.5M -$63K $5.0K $7.0K
Net Change in Cash $11.14M -$14.44M $25.41M -$198.7M $196.3M -$2.54M $799K $17.49M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -23.0% -25.6% --
Return on Assets (ROA) -21.8% -24.9% -22.4%
Current Ratio 26.17x 35.34x 17.14x
Quick Ratio 25.75x 34.82x 16.75x
Debt to Equity 0.02x 0.00x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -38.5% -32.4% -22.8% -23.0% -19.1% -33.5% -27.9% -25.6%
Return on Assets (ROA) -35.9% -29.9% -21.6% -21.8% -18.3% -30.9% -26.4% -24.9%
Current Ratio 20.07x 15.72x 27.08x 26.17x 36.37x 22.75x 31.01x 35.34x
Quick Ratio 19.46x 15.35x 26.64x 25.75x 35.83x 21.92x 30.42x 34.82x
Debt to Equity 0.02x 0.02x 0.02x 0.02x 0.02x 0.05x 0.03x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0002012593) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:28 UTC · Open in terminal